Aplastic anemia is a rare and heterogeneous disease that causes pancytopenia and aplasia of the bone marrow. It is characterized by a failure of hematopoiesis. It is believed that approximately 65% of cases of acquired aplastic anemia are idiopathic. In a subset of cases, a drug or infection is the cause of bone marrow failure. This case report presents a 38-year-old patient with axial spondylarthritis who developed pancytopenia and was diagnosed with aplastic anemia during anti-TNF-α treatment.
Keywords: Anti-TNF; Aplastic anemia; Etanercept; Thrombocytopenia.
© 2024. The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR).